Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine for Vasomotor Symptoms in Surgical Menopause
NCT06763484Phase 2Completed
- Sponsor
- Universidad Nacional Autónoma de Honduras
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vasomotor symptoms comparing Paroxetine with Placebo (2 arms). Primary endpoint: Menopause Rating Score at 12 weeks. Started Jan 2025; status: completed.
02
Drugs
paroxetine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT06763484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06763484.